Prognostic significance of serum adipokine levels in colorectal cancer patients

Fiorella Guadagni; Mario Roselli; Francesca Martini; Antonella Spila; Silvia Riondino; Roberta D'Alessandro; Girolamo Del Monte; Vincenzo Formica; Anastasia Laudisi; Ilaria Portarena; Raffaele Palmirotta; Patrizia Ferroni

Prognostic significance of serum adipokine levels in colorectal cancer patients

Fiorella Guadagni, Mario Roselli, Francesca Martini, Antonella Spila, Silvia Riondino, Roberta D'Alessandro, Girolamo Del Monte, Vincenzo Formica, Anastasia Laudisi, Ilaria Portarena, Raffaele Palmirotta, Patrizia Ferroni

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article

Abstract

Background: Adipokines may significantly influence the growth and proliferation of tumor stroma and malignant cells within. Reduced adiponectin and increased leptin serum levels were found in colorectal cancer (CRC) patients. Recently, it has been demonstrated that tumor necrosis factor-α (TNF-α) is able to induce dose-dependent changes in serum adipokine levels. Thus, aims of this study were to evaluate the possible associations between adipokines, TNF-α and clinicopathological variables of CRC patients and to analyze their possible prognostic value in predicting relapse-free and overall survival. Materials and Methods: Baseline leptin, adiponectin and TNF-α levels were analyzed in 90 patients with histologically diagnosed primary or newly diagnosed metastatic CRC treated at 'Tor Vergata' Clinical Center and followed up for a median period of 3 years. Results: Serum leptin levels were higher in CRC patients than in controls (p

Original language	English
Pages (from-to)	3321-3327
Number of pages	7
Journal	Anticancer Research
Volume	29
Issue number	8
Publication status	Published - Aug 2009

Fingerprint

Keywords

Adiponectin
Colorectal cancer
Leptin
Prognosis

ASJC Scopus subject areas

Cancer Research
Oncology

Cite this

Guadagni, F., Roselli, M., Martini, F., Spila, A., Riondino, S., D'Alessandro, R., Del Monte, G., Formica, V., Laudisi, A., Portarena, I., Palmirotta, R., & Ferroni, P. (2009). Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Research, 29(8), 3321-3327.

Prognostic significance of serum adipokine levels in colorectal cancer patients. / Guadagni, Fiorella; Roselli, Mario; Martini, Francesca; Spila, Antonella ; Riondino, Silvia; D'Alessandro, Roberta; Del Monte, Girolamo; Formica, Vincenzo; Laudisi, Anastasia; Portarena, Ilaria; Palmirotta, Raffaele; Ferroni, Patrizia.

In: Anticancer Research, Vol. 29, No. 8, 08.2009, p. 3321-3327.

Research output: Contribution to journal › Article

Guadagni, Fiorella ; Roselli, Mario ; Martini, Francesca ; Spila, Antonella ; Riondino, Silvia ; D'Alessandro, Roberta ; Del Monte, Girolamo ; Formica, Vincenzo ; Laudisi, Anastasia ; Portarena, Ilaria ; Palmirotta, Raffaele ; Ferroni, Patrizia. / Prognostic significance of serum adipokine levels in colorectal cancer patients. In: Anticancer Research. 2009 ; Vol. 29, No. 8. pp. 3321-3327.

@article{2f40a418551c4a3aad5a3aaa504038dc,

title = "Prognostic significance of serum adipokine levels in colorectal cancer patients",

abstract = "Background: Adipokines may significantly influence the growth and proliferation of tumor stroma and malignant cells within. Reduced adiponectin and increased leptin serum levels were found in colorectal cancer (CRC) patients. Recently, it has been demonstrated that tumor necrosis factor-α (TNF-α) is able to induce dose-dependent changes in serum adipokine levels. Thus, aims of this study were to evaluate the possible associations between adipokines, TNF-α and clinicopathological variables of CRC patients and to analyze their possible prognostic value in predicting relapse-free and overall survival. Materials and Methods: Baseline leptin, adiponectin and TNF-α levels were analyzed in 90 patients with histologically diagnosed primary or newly diagnosed metastatic CRC treated at 'Tor Vergata' Clinical Center and followed up for a median period of 3 years. Results: Serum leptin levels were higher in CRC patients than in controls (p",

keywords = "Adiponectin, Colorectal cancer, Leptin, Prognosis",

author = "Fiorella Guadagni and Mario Roselli and Francesca Martini and Antonella Spila and Silvia Riondino and Roberta D'Alessandro and {Del Monte}, Girolamo and Vincenzo Formica and Anastasia Laudisi and Ilaria Portarena and Raffaele Palmirotta and Patrizia Ferroni",

year = "2009",

month = aug

language = "English",

volume = "29",

pages = "3321--3327",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "8",

}

TY - JOUR

T1 - Prognostic significance of serum adipokine levels in colorectal cancer patients

AU - Guadagni, Fiorella

AU - Roselli, Mario

AU - Martini, Francesca

AU - Spila, Antonella

AU - Riondino, Silvia

AU - D'Alessandro, Roberta

AU - Del Monte, Girolamo

AU - Formica, Vincenzo

AU - Laudisi, Anastasia

AU - Portarena, Ilaria

AU - Palmirotta, Raffaele

AU - Ferroni, Patrizia

PY - 2009/8

Y1 - 2009/8

N2 - Background: Adipokines may significantly influence the growth and proliferation of tumor stroma and malignant cells within. Reduced adiponectin and increased leptin serum levels were found in colorectal cancer (CRC) patients. Recently, it has been demonstrated that tumor necrosis factor-α (TNF-α) is able to induce dose-dependent changes in serum adipokine levels. Thus, aims of this study were to evaluate the possible associations between adipokines, TNF-α and clinicopathological variables of CRC patients and to analyze their possible prognostic value in predicting relapse-free and overall survival. Materials and Methods: Baseline leptin, adiponectin and TNF-α levels were analyzed in 90 patients with histologically diagnosed primary or newly diagnosed metastatic CRC treated at 'Tor Vergata' Clinical Center and followed up for a median period of 3 years. Results: Serum leptin levels were higher in CRC patients than in controls (p

AB - Background: Adipokines may significantly influence the growth and proliferation of tumor stroma and malignant cells within. Reduced adiponectin and increased leptin serum levels were found in colorectal cancer (CRC) patients. Recently, it has been demonstrated that tumor necrosis factor-α (TNF-α) is able to induce dose-dependent changes in serum adipokine levels. Thus, aims of this study were to evaluate the possible associations between adipokines, TNF-α and clinicopathological variables of CRC patients and to analyze their possible prognostic value in predicting relapse-free and overall survival. Materials and Methods: Baseline leptin, adiponectin and TNF-α levels were analyzed in 90 patients with histologically diagnosed primary or newly diagnosed metastatic CRC treated at 'Tor Vergata' Clinical Center and followed up for a median period of 3 years. Results: Serum leptin levels were higher in CRC patients than in controls (p

KW - Adiponectin

KW - Colorectal cancer

KW - Leptin

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=68549117126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549117126&partnerID=8YFLogxK

M3 - Article

C2 - 19661351

AN - SCOPUS:68549117126

VL - 29

SP - 3321

EP - 3327

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 8

ER -

Prognostic significance of serum adipokine levels in colorectal cancer patients

Abstract

Fingerprint

Keywords

ASJC Scopus subject areas

Cite this

Access to Document